BayWa’s PwC Fallout Adds Legal Headache to Already Daunting Restructuring

The €107 million due from the Cefetra disposal at the end of April provides BayWa with some breathing room, but the cash injection does nothing to resolve the two existential questions hanging over the stricken agribusiness group: whether its core lenders will extend their standstill agreement, and how it will navigate a mounting legal assault that now directly implicates its former auditor.

Bank Decision Looms Over Everything

The group’s entire restructuring blueprint hinges on a single decision in the coming weeks. DZ Bank and HVB, BayWa’s key relationship banks, must agree to extend their standstill arrangement through to autumn 2026. Without that approval, the restructuring plan loses its legal foundation, leaving a financing gap of €2.7 billion. The Cefetra proceeds — €45 million from the direct sale and €62 million from the repayment of shareholder loans, due no later than 30 April 2026 or 90 days after closing — serve primarily as negotiating ammunition rather than a solution.

Debt Reduction Still a Distant Target

The Cefetra transaction, combined with earlier disposals including the Austrian RWA stake, has allowed BayWa to cut around €1.3 billion in liabilities. That represents roughly a third of the €4 billion deleveraging target set for 2028. The remaining distance is vast.

The original centrepiece of the programme — the sale of the BayWa r.e. renewable energy division — has collapsed. US subsidy cuts for renewables enacted in early 2025 destroyed the achievable price. Instead of an EBITDA of €230 million forecast for 2028, BayWa now expects the subsidiary to generate only around €150 million by 2030.

Operationally, the axe is swinging deep. Some 1,300 jobs will go by 2027, and 26 branches are closing permanently. The adjusted EBITDA target for 2027 has been cut to around €140 million, and the group has scrapped its 2026 annual forecast entirely. By the end of 2028, BayWa intends to shrink to four core divisions with revenue of roughly €10 billion.

PwC Under Fire as Legal Front Opens

A fresh legal dimension has emerged that threatens to complicate the restructuring further. Shareholder law firm TILP is preparing damages claims on behalf of investors who held BayWa shares between early 2022 and January 2026. The trigger is a formal reprimand from BaFin, the German financial regulator, which found that the 2023 management report omitted material details about a billion-euro loan and specific refinancing risks attached to a €500 million bond. The allegation is that BayWa misled shareholders and the capital market about price-sensitive facts.

Should investors sell immediately? Or is it worth buying BayWa?

PwC, the long-standing auditor, is now directly in the crosshairs alongside former management. The auditor issued an unqualified opinion on the 2023 consolidated accounts without flagging existential risks. Both BaFin and the audit oversight body Apas have opened proceedings against PwC. BayWa is putting the audit mandate out to tender from 2026, and the current board is examining whether to pursue damages claims against its former auditors.

The timing is particularly awkward. PwC will sign off on the 2025 financial year as its last engagement. Because of the delayed revaluation of BayWa r.e., the group does not expect to publish its 2025 accounts until the fourth quarter of 2026. Until then, there is no reliable basis for valuing the company.

T&G Sale in Play but Unlikely to Bridge the Gap

Goldman Sachs has been running the sale process for the New Zealand fruit trading subsidiary T&G Global since March 2026. Private equity firms Roc Partners, Paine Schwartz and Hancock are among the interested parties. The expected proceeds are around €300 million. However, Hong Kong-based minority shareholder Joy Wing Mau Group is complicating the process. Analysts caution that even a successful sale would barely dent the multibillion-euro financing shortfall.

Autumn 2026: The Defining Moment

The StaRUG restructuring proceeding, confirmed by the Munich court in June 2025, secures basic financing through to the end of 2027. But that framework is conditional on the banks extending their standstill until autumn 2026. If they refuse, the entire plan collapses.

The supervisory board has tightened its grip, lowering the threshold for transactions requiring its approval from €200 million to €50 million. Meanwhile, the Munich I public prosecutor’s office is investigating former chief executives Klaus Josef Lutz and Marcus Pöllinger on suspicion of breach of trust and misrepresentation in the 2023 annual accounts.

The share price tells its own story. At €14.35, the stock is roughly 14% below its level at the start of the year and has lost more than a third of its value since the 52-week high. It trades around 20% below its 200-day moving average. Real clarity will not arrive until the bank agreement is secured and the audited annual accounts are published — neither of which is expected before the fourth quarter of 2026.